High-dose Sequential Chemoimmunotherapy for B-cell Lymphomas With Central Nervous System Involvement
NCT00801216
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
B-cell Lymphomas
Interventions
DRUG:
High-dose sequential chemotherapy and autologous transplant
Sponsor
Andrés José Maria Ferreri
Collaborators
[object Object]